Syncom Formulations (India) Ltd Surges in Stock Market, Outperforms Sector by 7.41%

Sep 06 2024 09:37 AM IST
share
Share Via
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has seen a surge in its stock price, hitting a 52-week high of Rs. 23.99 on September 6th. This has caught the attention of investors and analysts, with MarketsMojo giving a 'Buy' call. The stock has been outperforming the sector and has seen a remarkable 171.43% increase in the past year.

Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent surge in share price. On September 6th, the company's stock hit a 52-week high of Rs. 23.99, which is also an all-time high for the company. This has caught the attention of investors and analysts, with MarketsMOJO giving a 'Buy' call for the stock.

The company's performance today has been impressive, outperforming the sector by 7.41%. This is a continuation of its upward trend, as the stock has been gaining for the last 3 days and has seen a 19.93% increase in returns during this period. The stock also touched an intraday high of Rs. 23.99, showing strong momentum.

In terms of moving averages, Syncom Formulations (India) is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. This indicates a positive trend for the stock and further reinforces the 'Buy' call by MarketsMOJO.

Looking at the company's performance over the past year, it has seen a remarkable 171.43% increase, outperforming the Sensex's performance of 24.77%. This is a testament to the company's growth and potential in the pharmaceutical industry.

Syncom Formulations (India) Ltd has been making strides in the smallcap market and its recent surge in share price is a reflection of its strong performance. With a positive outlook and impressive growth, the company is definitely one to watch in the pharmaceutical sector.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Syncom Formul. falling/rising?
Nov 25 2025 01:16 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 19 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 17 2025 08:10 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 16 2025 08:09 AM IST
share
Share Via
Is Syncom Formul. overvalued or undervalued?
Nov 15 2025 08:10 AM IST
share
Share Via